Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease
about
Timing of breast surgery in premenopausal breast cancer patientsVariation in natural killer activity in peripheral blood during the menstrual cycle.Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentiaPrognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal studySex hormones and the immune response in humans.Histopathology of breast cancer in relation to age.Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cellsTiming within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.Perioperative endocrine status and prognosis in early breast cancer.Natural killer cells in relation to disease and treatment.Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis.Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome?Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer.Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats.Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer.Comparison of natural killer activity during the first and second halves of the menstrual cycle in women.Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma.CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia.Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.The effect of surgical timing within the fertility cycle on breast cancer outcome.The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer.Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.
P2860
Q24234561-0DD07169-919F-40A8-B964-692061370BD6Q34489361-1E5A5FE6-E603-46B2-9C1E-9361F6089BD0Q35743162-F3E57C25-038E-4BE4-BAFA-2A29D6574C63Q36079936-1F4E5BD8-E005-47F6-8C71-C7978BAA8B73Q36080957-5F411947-1312-4221-8F5A-4BCA8628A880Q36092195-6CB0ADA1-61C7-4E64-A7F4-8FD2CDEC4D75Q36116041-A2B88FE0-55F6-4D99-B2C8-1BD09F4C30EFQ36136368-D850E56A-96BE-42C9-A1EA-DB2392079162Q36621650-311C79F5-78B6-42F9-85B8-D87E6D92AE36Q36621686-DF41E265-6C40-4A74-ABF9-A4C5BC3B9780Q36713318-B08679DB-7616-4570-BA88-ED0F5B71FD57Q39840358-8B54C66B-AFAC-4D14-94DB-B6AF8151C64FQ40221393-6BA782AF-6A12-40D8-A772-00A41AEA0654Q40751734-1E0FDC54-E379-4C23-B5D6-078425F7478AQ40767520-7D281D88-FF04-4111-BD89-20B9249071EBQ41085418-C235314E-A1F9-423B-B182-833E691D312FQ41503293-E684E025-A5B0-4708-B6E3-8488B2CDA11BQ42374307-F88D6172-9173-49D8-8AA4-6B6A210BFE9EQ42519385-8ACDE82F-0F94-48BB-84D3-49EA51726B3EQ42520846-B4A3214D-F988-48EC-9621-A9E3B4977B5BQ42842158-4CECA1B6-E967-46C8-9111-0B102597A1D9Q43785936-75338CA3-7DC3-4700-AE84-58DCD58C3D0DQ44731632-5A0C4E91-FF47-47CC-B0A0-7ED9FF4BFDD7Q45217477-5FC28389-44D2-4957-BB58-B91FFCAA788CQ46065849-1DC89364-2CFE-420C-A71C-072612B00FDCQ49275560-9F33C073-0EBE-4AA2-A00F-09819556DB28Q49386850-61508AB7-094A-4FDE-8D31-00F2173A7579
P2860
Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Natural killer (NK) activity i ...... n and malignant breast disease
@ast
Natural killer (NK) activity i ...... n and malignant breast disease
@en
type
label
Natural killer (NK) activity i ...... n and malignant breast disease
@ast
Natural killer (NK) activity i ...... n and malignant breast disease
@en
prefLabel
Natural killer (NK) activity i ...... n and malignant breast disease
@ast
Natural killer (NK) activity i ...... n and malignant breast disease
@en
P2093
P2860
P356
P1476
Natural killer (NK) activity i ...... n and malignant breast disease
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1982.245
P407
P577
1982-10-01T00:00:00Z